| Kapolei Profrssional Pharmacy | |
| 599 Farrington Hwy, Unit 100, Kapolei, Hawaii 96707 | |
| (808) 697-3784 |
| Name | Kapolei Profrssional Pharmacy |
|---|---|
| Organization Name | Waianae District Comprehensive Health And Hospital Board, Incorporated |
| Location | 599 Farrington Hwy, Unit 100, Kapolei, Hawaii 96707 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (808) 697-3784 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
AIDS Healthcare Foundation will host a protest Wednesday morning, May 12th at 10:30am targeting New York-based Bristol Myers Squibb Co. over the pricing and policies for its key HIV/AIDS drug, Reyataz, one of the most expensive first-line AIDS treatment in the US, during the Bank of America-Merrill Lynch 2010 Health Care Conference.
A compact, self-contained sensor recorded and transmitted brain activity data wirelessly for more than a year in early stage animal tests, according to a study funded by the National Institutes of Health.
Common genetic variations affecting nicotine receptors in the nervous system can significantly increase the chance that European Americans who begin smoking by age 17 will struggle with life-long nicotine addiction. Published July 11 in the open-access journal PLoS Genetics, this research - led by scientists at the University of Utah together with colleagues from the University of Wisconsin - highlights the importance of preventing early exposure to tobacco through public health policies.
The American Academy of Neurology and the American Brain Foundation are awarding the 2015 Potamkin Prize for Research in Pick's, Alzheimer's and Related Diseases to Peter Davies, PhD, of the Feinstein Institute for Medical Research in Manhasset, NY, and Reisa A. Sperling, MD, of the Brigham and Women's Hospital and Massachusetts General Hospital in Boston.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for malaria, HIV/AIDS, hepatitis, tuberculosis and detection, announced today the implementation of a program to accelerate the availability of the world's first Integrated Optical BioSensor (IOBS) platform. The Company is currently reviewing research and manufacturing partnerships to develop simple to replicate bench top versions of the IOBS platform on which single pathogen or multiple pathogen testing assay cartridges can be developed.
› Verified 1 days ago
| NPI Number | 1790081685 |
| Organization Name | WAIANAE DISTRICT COMPREHENSIVE HEALTH AND HOSPITAL BOARD, INCORPORATED |
| Doing Business As | KAPOLEI PROFESSIONAL PHARMACY |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 599 Farrington Hwy, Bldg #1, Unit 100, Kapolei, HI 96707 |
| Phone Number | 808-697-3784 |
News Archive
AIDS Healthcare Foundation will host a protest Wednesday morning, May 12th at 10:30am targeting New York-based Bristol Myers Squibb Co. over the pricing and policies for its key HIV/AIDS drug, Reyataz, one of the most expensive first-line AIDS treatment in the US, during the Bank of America-Merrill Lynch 2010 Health Care Conference.
A compact, self-contained sensor recorded and transmitted brain activity data wirelessly for more than a year in early stage animal tests, according to a study funded by the National Institutes of Health.
Common genetic variations affecting nicotine receptors in the nervous system can significantly increase the chance that European Americans who begin smoking by age 17 will struggle with life-long nicotine addiction. Published July 11 in the open-access journal PLoS Genetics, this research - led by scientists at the University of Utah together with colleagues from the University of Wisconsin - highlights the importance of preventing early exposure to tobacco through public health policies.
The American Academy of Neurology and the American Brain Foundation are awarding the 2015 Potamkin Prize for Research in Pick's, Alzheimer's and Related Diseases to Peter Davies, PhD, of the Feinstein Institute for Medical Research in Manhasset, NY, and Reisa A. Sperling, MD, of the Brigham and Women's Hospital and Massachusetts General Hospital in Boston.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for malaria, HIV/AIDS, hepatitis, tuberculosis and detection, announced today the implementation of a program to accelerate the availability of the world's first Integrated Optical BioSensor (IOBS) platform. The Company is currently reviewing research and manufacturing partnerships to develop simple to replicate bench top versions of the IOBS platform on which single pathogen or multiple pathogen testing assay cartridges can be developed.
› Verified 1 days ago
News Archive
AIDS Healthcare Foundation will host a protest Wednesday morning, May 12th at 10:30am targeting New York-based Bristol Myers Squibb Co. over the pricing and policies for its key HIV/AIDS drug, Reyataz, one of the most expensive first-line AIDS treatment in the US, during the Bank of America-Merrill Lynch 2010 Health Care Conference.
A compact, self-contained sensor recorded and transmitted brain activity data wirelessly for more than a year in early stage animal tests, according to a study funded by the National Institutes of Health.
Common genetic variations affecting nicotine receptors in the nervous system can significantly increase the chance that European Americans who begin smoking by age 17 will struggle with life-long nicotine addiction. Published July 11 in the open-access journal PLoS Genetics, this research - led by scientists at the University of Utah together with colleagues from the University of Wisconsin - highlights the importance of preventing early exposure to tobacco through public health policies.
The American Academy of Neurology and the American Brain Foundation are awarding the 2015 Potamkin Prize for Research in Pick's, Alzheimer's and Related Diseases to Peter Davies, PhD, of the Feinstein Institute for Medical Research in Manhasset, NY, and Reisa A. Sperling, MD, of the Brigham and Women's Hospital and Massachusetts General Hospital in Boston.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for malaria, HIV/AIDS, hepatitis, tuberculosis and detection, announced today the implementation of a program to accelerate the availability of the world's first Integrated Optical BioSensor (IOBS) platform. The Company is currently reviewing research and manufacturing partnerships to develop simple to replicate bench top versions of the IOBS platform on which single pathogen or multiple pathogen testing assay cartridges can be developed.
› Verified 1 days ago
Longs Drugs #09317 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 590 Farrington Hwy, Kapolei, Hawaii 96707 Phone: (808) 674-0269 | |
Longs Drugs #17471 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4450 Kapolei Pkwy, Kapolei, Hawaii 96707 Phone: (808) 457-3680 | |
Medline Industries, Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2341 Lauwiliwili St, Kapolei, Hawaii 96707 Phone: (808) 682-5712 | |
Kapolei Profrssional Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 599 Farrington Hwy, Kapolei, Hawaii 96707 Phone: (808) 697-3784 | |
Wal-mart Pharmacy 10-3883 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 91-600 Farrington Hwy, Kapolei, Hawaii 96707 Phone: (808) 206-9415 |